# Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

> **NCT02832362** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 30 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Carbomer 980
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02832362
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-11
- **Primary completion:** 2016-07-10
- **Final completion:** 2016-07-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02832362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02832362, "Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02832362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*